SCHEMBL9610318

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL9610317	0.84	MEN1 (0.36)	GSK3BADKDNMT1MAPTMEN1
	SCHEMBL9610323	0.84	ELANE (0.39)	MAPTKMT2ANSD2ALDH1A1ELANE
	SCHEMBL11964310	0.83	ALDH1A1 (0.33)	DNMT1MAPTMEN1KMT2ANPSR1
	SCHEMBL19771480	0.82	DNMT1 (0.35)	DNMT1MAPTMEN1KMT2ANSD2
	SCHEMBL9610310	0.82	GSK3B (0.36)	GSK3BADKDNMT1MAPTMEN1
	SCHEMBL18826210	0.82	PDK2 (0.30)	—
	SCHEMBL9610541	0.80	ALDH1A1 (0.37)	MAPTMEN1KMT2ANSD2ALDH1A1
	SCHEMBL9610312	0.80	PDK2 (0.36)	MAPTMEN1KMT2AALDH1A1ELANE
	SCHEMBL9610314	0.79	GSK3B (0.34)	GSK3BADKDNMT1MAPTMEN1
	SCHEMBL9610319	0.79	MEN1 (0.36)	GSK3BADKDNMT1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.